US-based PhRMA has used its submission to the Office of the USTR 2023 Special 301 Report to call for Australia's inclusion in the agency's 'Watch List' and welcomed a possible first meeting of the government-to-government working group in 15 years. …
US-based industry wants Australia added to trade 'Watch List' over FTA breaches
February 6, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - - Latest News -
Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines
February 16, 2026 - - Latest News -
Director pay rises across ASX healthcare sector, but gender balance remains uneven
February 16, 2026 - - Latest News -
Life sciences sector unites to advance women’s leadership at landmark 2026 events
February 16, 2026 - - Latest News -
New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial
February 16, 2026 - - Australian Biotech -
Medibank funding expansion signals momentum for Emyria’s mental health model
February 16, 2026 - - Latest News -
IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending
February 16, 2026 - - Latest News